TPA-APIs- Yung Zip Chem.

CPHI Milan is THE place to spark new ideas, forge meaningful connections, and shape the future of Pharma, and we are excited to announce TPA's exhibitions at CPHI Milan this year. Our booth is No. 8J7. 

Taiwan Pharmaceutical Alliance (TPA) unites 24 Taiwan pharmaceutical companies at  least with diverse expertise in products and dosage forms.

We provide end-to-end solutions, from drug R&D and clinical trials to finished product manufacturing, with advanced technologies including hot-melt extrusion, nano-grinding, continuous manufacturing, LAIs, OROS, and PFS.Our members comply with PIC/S GMP standards and have successfully passed inspections by the U.S. FDA, PMDA, EMA, and MENA authorities, demonstrating our commitment to quality and reliable supply.We are seeking international partners to explore global opportunities together. 

We would be delighted to meet you at CPHI Milan and discuss potential collaboration.

Taiwan Pharmaceutical Alliance is your trusted pharmaceutical partner in Taiwan, offering high-quality manufacturing capabilities aligned with PIC/S GMP standards.

Our members provide diverse expertise in specialized dosage forms, technologies, and production capacities, delivering flexible and customized solutions for global pharmaceutical needs. We also support partners in building a resilient and reliable pharmaceutical supply chain.

With extensive export experience and regulatory approvals and inspections across the U.S., Japan, Australia, Europe, the U.K., and the Middle East, our members are well equipped to serve international markets.

We are actively seeking global partners to build long-term collaborations and create mutual success and win-win opportunities.

OEP Group is a global science-based company specializing in health, nutrition, pharmaceuticals, and cosmeceuticals. Established in 1982, Orient EuroPharma Co., Ltd. (OEP) has led innovation and became publicly listed on the Taipei Exchange in 2003 (stock code: 4120). To expand its capabilities, OEP founded OrientPHARMA (stock code: 4166) in 2008 and OP NanoPharma in 2014, focusing on new drug development and manufacturing. 

This vertical integration enhances expertise across pharmaceutical R&D, clinical development, production, and marketing. OEP also provides comprehensive CDMO services at its US FDA and PIC/S GMP-certified facility, specializing in injectable product development, aseptic filling, lyophilization, and analytical services.
 
With a strong commitment to quality and innovation, OEP Group continues advancing science and healthcare globally, delivering solutions that improve health and well-being.

UBI Pharma Inc. (UBIP) is one of the leading pharmaceutical companies in Taiwan. UBIP specializes in developing and manufacturing high quality generics and fusion protein drugs, as well as providing contract development and manufacturing services to global clients.

UBIP's facility is routinely inspected by TFDA, USFDA and PMDA. We are capable of manufacturing finished dosage form of Sterile (Vial, Ampoule and Lyophilized) and Non-Sterlie (Tablet, Capsule, Powder, Cream and Ointment), and have been the contract manufacturer for multiple world renowned pharmaceutical companies for more than 20 years.
UBIP is also proud of being nominated by the goverment to manufactruring controlled drugs and COVID-19 vaccines.

UBIP continues to seek global partners to provide High-Quality, Affordable, and Innovative Medicines that help patients lead healthier lives.

Controlled API, Originator new drug for nephrology (Nephoxil & Fexenol) and innovation Aesthetic products